HomeFENC • NASDAQ
add
Fennec Pharmaceuticals Inc
Previous close
$6.62
Day range
$6.45 - $6.77
Year range
$3.96 - $11.47
Market cap
183.60M USD
Avg Volume
90.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 7.92M | -18.59% |
Operating expense | 8.19M | -24.64% |
Net income | -1.62M | 39.63% |
Net profit margin | -20.43 | 25.84% |
Earnings per share | -0.06 | 55.75% |
EBITDA | -909.00K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.63M | 100.72% |
Total assets | 44.95M | 67.31% |
Total liabilities | 50.45M | 31.09% |
Total equity | -5.51M | — |
Shares outstanding | 27.29M | — |
Price to book | -33.10 | — |
Return on assets | -4.50% | — |
Return on capital | -11.39% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.62M | 39.63% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1996
Headquarters
Website
Employees
29
